Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

"Simultaneous regulatory submissions for two indications highlight our confidence in depemokimab to help reduce the burden of both asthma ... products. It is one of five key product launches that ...

GSK's severe asthma therapy Nucala could find a new lease ... The drug remains one of GSK's top products, with sales of £856 million ($1.1 billion) in the first half of this year, up 15%.

After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...

Patients with asthma who used depemokimab tolerated treatment well while experiencing reductions in rates of clinically ...

The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...

Healthy fats and proteins such as avocados and nuts have anti-inflammatory properties for allergic asthma. Learn which foods to eat and avoid.

From snake oil to cigarettes for asthma patients, the Pharmacy Museum is a trip through decades of healthcare evolution in ...

Mar. 12, 2025 — A lung function test used to help diagnose asthma works better in the morning, becoming less reliable throughout the day, researchers have found. Using real world data from 1,600 ...